Gurugram, India

Bharat Sharma

This inventor holds 2 USPTO granted patents. Top assignee: Mankind Pharma Ltd.. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bharat Sharma. Retrieved from https://idiyas.com/inventor/bharat-sharma-ed4wpj9d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bharat Sharma - Innovator in Pharmaceutical Composition

Introduction

Bharat Sharma is a notable inventor based in Gurugram, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of fixed-dose combinations for treating various diseases. With a total of two patents to his name, Sharma's work is recognized for its potential impact on healthcare.

Latest Patents

Bharat Sharma's latest patents include a fixed-dose pharmaceutical composition of valsartan and sacubitril. This invention relates to a pharmaceutical composition comprising a fixed-dose combination of valsartan or pharmaceutically acceptable salts thereof and sacubitril or pharmaceutically acceptable salts thereof. Furthermore, this invention also details the process for the preparation of said composition and its use in the treatment of certain diseases.

Career Highlights

Sharma is currently associated with Mankind Pharma Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on improving drug formulations to enhance patient outcomes.

Collaborations

Some of his coworkers include K S Hareen and P V S Narasimham, who collaborate with him on various projects within the company.

Conclusion

Bharat Sharma's contributions to pharmaceutical innovations highlight his commitment to advancing healthcare solutions. His work in developing fixed-dose combinations is paving the way for more effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…